Cargando…
Rocaglamide Prolonged Allograft Survival by Inhibiting Differentiation of Th1/Th17 Cells in Cardiac Transplantation
BACKGROUND: Aglaia (Meliaceae) species are used for treating autoimmune disorders and allergic diseases in Asian countries. Rocaglamide, an extract obtained from Aglaia species, exhibits suppressive effect by regulating the T cell subset balance and cytokine network in cancer. However, whether it ca...
Autores principales: | Dai, Chen, Zhou, Xi, Wang, Lu, Tan, Rumeng, Wang, Wei, Yang, Bo, Zhang, Yucong, Shi, Huibo, Chen, Dong, Wei, Lai, Chen, Zhishui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787457/ https://www.ncbi.nlm.nih.gov/pubmed/35087613 http://dx.doi.org/10.1155/2022/2048095 |
Ejemplares similares
-
Progress in the Total Synthesis of Rocaglamide
por: Cai, Xiao-hua, et al.
Publicado: (2011) -
Assessment of Survival of Pediatric Patients With Hepatoblastoma Who Received Chemotherapy Following Liver Transplant or Liver Resection
por: Feng, Jincheng, et al.
Publicado: (2019) -
Host-Based Th2 Cell Therapy for Prolongation of Cardiac Allograft Viability
por: Amarnath, Shoba, et al.
Publicado: (2011) -
Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation
por: LUAN, ZHOU, et al.
Publicado: (2015) -
The Ratio of Circulating Regulatory T Cells (Tregs)/Th17 Cells Is Associated with Acute Allograft Rejection in Liver Transplantation
por: Wang, Ying, et al.
Publicado: (2014)